Human neutralizing antibodies for SARS-CoV-2 prevention and immunotherapy.

Zhou, Dongyan; Zhou, Runhong; Chen, Zhiwei

Zhou, Dongyan; Zhou, Runhong; Chen, Zhiwei.

Afiliação

Zhou D; AIDS Institute and Department of Microbiology, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region (SAR), People's Republic of China.
Zhou R; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR, People's Republic of China.
Chen Z; AIDS Institute and Department of Microbiology, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region (SAR), People's Republic of China.

Immunother Adv ; 2(1): ltab027, 2022.

Article em En | MEDLINE | ID: mdl-35915816

Palavras-chave

SARS-CoV-2; immunotherapy; neutralizing antibody; passive immunization; vaccine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Immunother Adv Ano de publicação: 2022 Tipo de documento: Article